Systematic Financial Management LP Sells 2,503 Shares of National HealthCare Corporation $NHC

Systematic Financial Management LP lessened its holdings in National HealthCare Corporation (NYSEAMERICAN:NHC) by 2.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 116,248 shares of the company’s stock after selling 2,503 shares during the quarter. Systematic Financial Management LP’s holdings in National HealthCare were worth $18,565,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of NHC. Morgan Stanley Institutional Investment Advisors LLC grew its position in shares of National HealthCare by 38.6% in the 4th quarter. Morgan Stanley Institutional Investment Advisors LLC now owns 1,038,787 shares of the company’s stock valued at $142,407,000 after acquiring an additional 289,566 shares during the period. First Trust Advisors LP raised its stake in National HealthCare by 45.4% in the 1st quarter. First Trust Advisors LP now owns 530,302 shares of the company’s stock valued at $84,689,000 after acquiring an additional 165,615 shares during the period. Geode Capital Management LLC raised its stake in National HealthCare by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 318,440 shares of the company’s stock valued at $43,662,000 after acquiring an additional 2,361 shares during the period. Goldman Sachs Group Inc. lifted its holdings in National HealthCare by 43.5% during the 4th quarter. Goldman Sachs Group Inc. now owns 85,781 shares of the company’s stock valued at $11,760,000 after purchasing an additional 26,020 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in National HealthCare by 21.1% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 58,466 shares of the company’s stock valued at $7,625,000 after purchasing an additional 10,170 shares during the last quarter. Institutional investors own 56.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. The Goldman Sachs Group raised shares of National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. BMO Capital Markets upgraded shares of National HealthCare to a “hold” rating in a research note on Monday, May 18th. Robert W. Baird raised shares of National HealthCare to a “strong-buy” rating in a report on Monday, May 18th. Finally, Royal Bank Of Canada upgraded shares of National HealthCare to a “hold” rating in a research report on Monday, May 18th. Two investment analysts have rated the stock with a Strong Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy”.

National HealthCare Price Performance

NHC stock opened at $221.51 on Friday. The stock has a market capitalization of $3.46 billion, a price-to-earnings ratio of 28.15 and a beta of 0.63. The business’s fifty day moving average price is $202.45 and its two-hundred day moving average price is $174.86. National HealthCare Corporation has a fifty-two week low of $93.54 and a fifty-two week high of $232.25.

National HealthCare (NYSEAMERICAN:NHC) last announced its earnings results on Thursday, May 7th. The company reported $1.91 earnings per share (EPS) for the quarter. The company had revenue of $381.82 million during the quarter. National HealthCare had a net margin of 8.10% and a return on equity of 9.98%.

National HealthCare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be given a $0.67 dividend. The ex-dividend date is Tuesday, June 30th. This is a positive change from National HealthCare’s previous quarterly dividend of $0.64. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.2%. National HealthCare’s dividend payout ratio (DPR) is presently 61.89%.

Insider Buying and Selling at National HealthCare

In related news, Director Lisa Piercey purchased 949 shares of the business’s stock in a transaction that occurred on Monday, June 1st. The stock was acquired at an average cost of $184.26 per share, for a total transaction of $174,862.74. Following the completion of the purchase, the director owned 949 shares in the company, valued at approximately $174,862.74. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 13.92% of the company’s stock.

National HealthCare Company Profile

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.